Dyanavel is an extended-release liquid formulation of the stimulant medication methylphenidate, used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals aged 6 years and older. It is designed to be taken once daily [1].
How does Dyanavel work?
Dyanavel XR (methylphenidate hydrochloride extended-release) works by increasing the levels of certain neurotransmitters in the brain, specifically dopamine and norepinephrine. These neurotransmitters are believed to play a role in attention and impulse control. By modulating these chemicals, Dyanavel helps improve focus and reduce hyperactivity and impulsivity in individuals with ADHD [1].
What is the difference between Dyanavel and other ADHD medications?
Dyanavel XR is a liquid formulation of methylphenidate, offering a different administration route compared to pills or capsules. Its extended-release mechanism is designed to provide symptom control over a full day with a single dose. Other ADHD medications may contain different active ingredients, such as amphetamines, or be formulated for immediate release or different durations of action [2]. The choice of medication often depends on individual patient response, duration of effect needed, and administration preferences.
When does Dyanavel's patent expire?
Information regarding specific patent expiration dates for Dyanavel XR is available through resources like DrugPatentWatch.com. These patents are crucial for understanding when generic versions of the medication may become available, potentially impacting pricing and accessibility [3].
Who makes Dyanavel?
Dyanavel XR is manufactured by Tris Pharma [1].
What are the potential side effects of Dyanavel?
Common side effects reported with Dyanavel XR include decreased appetite, insomnia, anxiety, irritability, stomach pain, nausea, and weight loss. More serious side effects can occur, such as psychiatric problems (hallucinations, mania, aggression), circulation problems in fingers and toes, and slowed growth in children. It is important for patients and caregivers to discuss any concerns with a healthcare provider [1].
How is Dyanavel administered?
Dyanavel XR is administered orally, typically once daily in the morning. It is provided as a liquid suspension, which can be beneficial for individuals who have difficulty swallowing pills. The medication should be taken as prescribed by a healthcare professional, and the dosage may be adjusted based on the patient's response [1].